

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>ImmunGlobuline To TargetDisease Mapping - JSON Representation - CH Term (R4) v3.3.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
  	<link href="assets/css/cqf.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/hl7.css" rel="stylesheet"/>
    <link href="assets/css/fhir.css" rel="stylesheet"/>

    <style>
    

    

    

    </style>
 

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/icon-fhir-144.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/icon-fhir-114.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/icon-fhir-72.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/icon-fhir-57.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>
    <script type="text/javascript" src="assets/js/mermaid.js"></script>
    <script type="text/javascript" src="assets/js/mermaid-init.js"></script>
    <style type="text/css">h2{--heading-prefix:"8.138"}
    h3,h4,h5,h6{--heading-prefix:"8.138"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->

        <!-- Placeholder for child template header declarations -->

            <!--
<div id="family-nav">
	<a id="logo" no-external="true" href="http://hl7.org/fhir"> <img
		alt="logo fhir" src="assets/images/fhir-logo-www.png" />
	</a>
</div>
-->


            <div id="family-nav">
                <a id="logo" no-external="true" href="searchform.html">
                    <img src="assets/images/search.png" alt="Search FHIR" />
                </a>
            </div>
            <div id="hl7-nav">
    <a id="hl7-logo" no-external="true" href="http://www.hl7.ch">
        <img alt="visit the hl7 website" height="50" src="hl7-logo.png" />
    </a>            
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">CH Term (R4)</span>
            <br/>
            <span style="display:inline-block;">3.3.0 - trial-use



  <img alt="Switzerland flag" src="assets/images/che.svg" height="16" title="Switzerland"/>


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Guidance
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="guidance.html#snomed-ct-swiss-extension">SNOMED CT Swiss Extension</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="codesystems.html">Code Systems</a>
  </li>
  <li>
    <a href="valuesets.html">Value Sets</a>
  </li>
  <li>
    <a href="conceptmaps.html">Concept Maps</a>
  </li>
  <li>
    <a href="namingsystems.html">Naming Systems</a>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>ImmunGlobuline To TargetDisease Mapping</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div style="counter-reset: section 8" class="col-12">
<!--ReleaseHeader--><p id="publish-box">This page is part of the CH Term (R4) (v3.3.0: <a data-no-external="true" href="https://confluence.hl7.org/display/HL7/HL7+Balloting" title="Standard for Trial-Use">STU</a>) based on <a data-no-external="true" href="http://hl7.org/fhir/R4">FHIR (HL7® FHIR® Standard) R4</a>. This is the current published version.  For a full list of available versions, see the <a data-no-external="true" href="http://fhir.ch/ig/ch-term/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->









<ul class="nav nav-tabs">

  <li>
    <a href="ConceptMap-ch-vacd-immunoglobulin-targetdiseases-cm.html">Narrative Content</a>
  </li>



  
    <li>
      <a href="ConceptMap-ch-vacd-immunoglobulin-targetdiseases-cm.xml.html">XML</a>
    </li>
  


  
    <li class="active">
      <a href="#">JSON</a>
    </li>
  




</ul>


<a name="root"> </a>


<h2 id="root">: ImmunGlobuline To TargetDisease Mapping - JSON Representation</h2>

  <table class="colsi">
    <tr>

      <td colspan="2">
        
          Active
          
            as of 2025-12-15
          
        
      </td>

    </tr>
  </table>


<p><a href="ConceptMap-ch-vacd-immunoglobulin-targetdiseases-cm.json" no-download="true">Raw json</a> | <a href="ConceptMap-ch-vacd-immunoglobulin-targetdiseases-cm.json" download>Download</a></p>

  <!-- insert intro if present -->
  



  <pre class="json" data-fhir="generated" style="white-space: pre; text-wrap: nowrap; width: auto;"><code style="white-space: pre; text-wrap: nowrap;">{
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap">resourceType</a>" : "ConceptMap",
  "<a href="http://hl7.org/fhir/R4/resource.html#ConceptMap.id">id</a>" : "ch-vacd-immunoglobulin-targetdiseases-cm",
  "<a href="http://hl7.org/fhir/R4/domainresource.html#ConceptMap.text">text</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.status">status</a>" : "generated",
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.div">div</a>" : "&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p class=\&quot;res-header-id\&quot;&gt;&lt;b&gt;Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm&lt;/b&gt;&lt;/p&gt;&lt;a name=\&quot;ch-vacd-immunoglobulin-targetdiseases-cm\&quot;&gt; &lt;/a&gt;&lt;a name=\&quot;hcch-vacd-immunoglobulin-targetdiseases-cm\&quot;&gt; &lt;/a&gt;&lt;p&gt;Mapping from &lt;a href=\&quot;ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.html\&quot;&gt;CH VACD Swissmedic Authorized Immunoglobulin Codes&lt;/a&gt; to &lt;a href=\&quot;ValueSet-ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs.html\&quot;&gt;CH VACD Target disease and illnesses undergone for immunization&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p&gt;&lt;b&gt;Group 1 &lt;/b&gt;Mapping from &lt;a href=\&quot;CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\&quot;&gt;CH VACD Swissmedic Authorized Immunoglobulin Codes&lt;/a&gt; to &lt;a href=\&quot;http://hl7.org/fhir/R4/codesystem-snomedct.html\&quot;&gt;SNOMED CT (all versions)&lt;/a&gt;&lt;/p&gt;&lt;table class=\&quot;grid\&quot;&gt;&lt;tr&gt;&lt;td colspan=\&quot;2\&quot;&gt;&lt;b&gt;Source Concept Details&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/td&gt;&lt;td colspan=\&quot;2\&quot;&gt;&lt;b&gt;Target Concept Details&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=\&quot;2\&quot;&gt;&lt;b&gt;Codes&lt;/b&gt; from &lt;a href=\&quot;CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\&quot; title=\&quot;http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs\&quot;&gt;CH VACD Swissmedic Authorized Immunoglobulin Codes&lt;/a&gt;&lt;/td&gt;&lt;td/&gt;&lt;td colspan=\&quot;2\&quot;&gt;&lt;b&gt;Codes&lt;/b&gt; from &lt;a href=\&quot;http://hl7.org/fhir/R4/codesystem-snomedct.html\&quot; title=\&quot;http://snomed.info/sct\&quot;&gt;SNOMED CT (all versions)&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00687-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Berirab 2 ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;14168008&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Rabies (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00687-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Berirab 5 ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;14168008&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Rabies (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;69039-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;55735004&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Respiratory syncytial virus infection (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;69039-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;55735004&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Respiratory syncytial virus infection (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;68222-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Cutaquig 165 mg/ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;65992-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Cuvitru 200 mg/ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00506-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Cytotect CP Biotest, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;28944009&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Infection caused by Cytomegalovirus (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;00701-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Gammanorm, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;16318001000119107&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Hypogammaglobulinemia due to multiple myeloma (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00668-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Gamunex 10%, solution pour injection intraveineuse&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;14189004&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Measles (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00488-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Hepatect CP, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00674-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Hepatitis-B-Immunglobulin Behring, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66410-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;61547-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Hizentra, Injektionslösung zur s.c. Anwendung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66684-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;58157-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Ig Vena Kedrion 50 g/I, solution pour infusion&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;62913-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Intratect 10%, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;57676-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Intratect 5%, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66332-03&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Iqymune 10g/100ml, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66332-04&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Iqymune 20g/200ml, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66332-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Iqymune 2g/20ml, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;66332-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Iqymune 5g/50ml, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;57469-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Kiovig, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;60323-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Octagam 10 %, Lösung zur intravenösen Anwendung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-bottom-style: none\&quot;&gt;58314-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px; border-bottom-style: none\&quot;&gt;Privigen, Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;58606001&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Primary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px; border-top-style: none\&quot;/&gt;&lt;td style=\&quot;border-top-style: none; border-left-width: 0px\&quot;/&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;33286000&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Secondary immune deficiency disorder (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;53609-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Rhophylac 300, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;165746003&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;RhD negative (finding)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;65695-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Synagis 100 mg/1 ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;55735004&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Respiratory syncytial virus infection (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;65695-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Synagis 50 mg/0.5 ml, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;55735004&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Respiratory syncytial virus infection (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;00673-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Tetagam P, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;76902006&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Tetanus (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;59374-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Uman Big 180 UI/1 ml, solution pour injection intramusculaire&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;59374-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Uman Big 540 UI/3 ml, solution pour injection intramusculaire&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;59451-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Varitect CP, Lösung zur intravenösen Injektion&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;38907003&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Varicella (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;59373-02&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;59373-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;68471-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Xevudy, Konzentrat zur Herstellung einer Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;840539006&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66344-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Zinplava, Konzentrat zur Herstellung einer Infusionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;56688005&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Clostridial infection (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;61639-01&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Zutectra, Injektionslösung&lt;/td&gt;&lt;td&gt;&lt;a href=\&quot;http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\&quot; title=\&quot;relatedto\&quot;&gt;is related to&lt;/a&gt;&lt;/td&gt;&lt;td style=\&quot;border-right-width: 0px\&quot;&gt;66071002&lt;/td&gt;&lt;td style=\&quot;border-left-width: 0px\&quot;&gt;Viral hepatitis type B (disorder)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;"
  },
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.url">url</a>" : "http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.version">version</a>" : "3.3.0",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.name">name</a>" : "ImmunGlobulineToTargetDiseaseMapping",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.title">title</a>" : "ImmunGlobuline To TargetDisease Mapping",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.status">status</a>" : "active",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.experimental">experimental</a>" : false,
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.date">date</a>" : "2025-12-15T10:47:47+00:00",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.publisher">publisher</a>" : "HL7 Switzerland",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.contact">contact</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.name">name</a>" : "HL7 Switzerland",
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.telecom">telecom</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.system">system</a>" : "url",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.value">value</a>" : "https://www.hl7.ch/"
        }
      ]
    },
    {
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.name">name</a>" : "HL7 Switzerland",
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.telecom">telecom</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.system">system</a>" : "url",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.value">value</a>" : "https://www.hl7.ch/",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.use">use</a>" : "work"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.description">description</a>" : "Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.jurisdiction">jurisdiction</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "urn:iso:std:iso:3166",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "CH"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.copyright">copyright</a>" : "This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.source_x_">sourceUri</a>" : "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.target_x_">targetUri</a>" : "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs",
  "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group">group</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.source">source</a>" : "http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs",
      "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.target">target</a>" : "http://snomed.info/sct",
      "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element">element</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00687-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Berirab 2 ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "14168008",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Rabies (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00687-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Berirab 5 ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "14168008",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Rabies (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "69039-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "55735004",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Respiratory syncytial virus infection (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "69039-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "55735004",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Respiratory syncytial virus infection (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "68222-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Cutaquig 165 mg/ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "65992-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Cuvitru 200 mg/ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00506-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Cytotect CP Biotest, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "28944009",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Infection caused by Cytomegalovirus (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00701-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Gammanorm, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "16318001000119107",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Hypogammaglobulinemia due to multiple myeloma (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00668-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Gamunex 10%, solution pour injection intraveineuse",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "14189004",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Measles (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00488-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Hepatect CP, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00674-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Hepatitis-B-Immunglobulin Behring, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66410-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "61547-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Hizentra, Injektionslösung zur s.c. Anwendung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66684-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "58157-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Ig Vena Kedrion 50 g/I, solution pour infusion",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "62913-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Intratect 10%, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "57676-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Intratect 5%, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66332-03",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Iqymune 10g/100ml, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66332-04",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Iqymune 20g/200ml, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66332-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Iqymune 2g/20ml, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66332-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Iqymune 5g/50ml, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "57469-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Kiovig, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "60323-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Octagam 10 %, Lösung zur intravenösen Anwendung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "58314-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Privigen, Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "58606001",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Primary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            },
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "33286000",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Secondary immune deficiency disorder (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "53609-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Rhophylac 300, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "165746003",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "RhD negative (finding)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "65695-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Synagis 100 mg/1 ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "55735004",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Respiratory syncytial virus infection (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "65695-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Synagis 50 mg/0.5 ml, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "55735004",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Respiratory syncytial virus infection (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "00673-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Tetagam P, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "76902006",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Tetanus (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "59374-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Uman Big 180 UI/1 ml, solution pour injection intramusculaire",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "59374-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Uman Big 540 UI/3 ml, solution pour injection intramusculaire",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "59451-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Varitect CP, Lösung zur intravenösen Injektion",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "38907003",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Varicella (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "59373-02",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "59373-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "68471-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Xevudy, Konzentrat zur Herstellung einer Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "840539006",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "66344-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Zinplava, Konzentrat zur Herstellung einer Infusionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "56688005",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Clostridial infection (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        },
        {
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.code">code</a>" : "61639-01",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.display">display</a>" : "Zutectra, Injektionslösung",
          "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target">target</a>" : [
            {
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.code">code</a>" : "66071002",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.display">display</a>" : "Viral hepatitis type B (disorder)",
              "<a href="http://hl7.org/fhir/R4/conceptmap.html#ConceptMap.group.element.target.equivalence">equivalence</a>" : "relatedto"
            }
          ]
        }
      ]
    }
  ]
}</code></pre>


  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript" src="assets/js/window-hash.js"> </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2019+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.hl7.ch/">HL7 Switzerland</a>.  Package ch.fhir.ig.ch-term#3.3.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Mon, Dec 15, 2025 10:47+0000">2025-12-15</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                

| <a style="color: #81BEF7" target="_blank" href="https://docs.google.com/forms/d/e/1FAIpQLSfmseqplMwDJ738LuM1TtvkdjUMgik-yuIzd2I9pnZb-ZiHeA/viewform?usp=sf_link&amp;entry%2E1353807103=ch.fhir.ig.ch-term%233.3.0%20/ConceptMap-ch-vacd-immunoglobulin-targetdiseases-cm.json.html&amp;entry%2E247644557=ImmunGlobuline%20To%20TargetDisease%20Mapping%20-%20JSON%20Representation">Propose a change</a>




          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->

  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script type="text/javascript" src="assets/js/anchor-hover.js"> </script>
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

